| Market Capitalization (Millions $) |
13 |
| Shares
Outstanding (Millions) |
47 |
| Employees |
34 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-63 |
| Cash Flow (TTM) (Millions $) |
22 |
| Capital Exp. (TTM) (Millions $) |
5 |
Beyond Air Inc
Beyond Air Inc. is a medical device company that develops and commercializes innovative therapies for respiratory conditions. The company focuses on utilizing its proprietary technology called Nitric Oxide Generator and Delivery System to produce and deliver nitric oxide (NO) to patients.
Nitric oxide plays a crucial role in various physiological processes, including vasodilation and antimicrobial defense. Beyond Air harnesses the therapeutic potential of NO by creating a system that delivers precise concentrations of the gas directly to the respiratory system.
The primary focus of Beyond Air is on developing therapies for respiratory conditions like bronchiolitis and chronic obstructive pulmonary disease (COPD). They aim to address the unmet needs of patients by developing NO-based treatments that are safe, effective, and easy to administer.
Beyond Air's innovative technology enables the delivery of NO gas through a user-friendly system, eliminating the need for bulky tanks or complex equipment. This makes their therapies suitable for use in various healthcare settings, including hospitals, clinics, and home environments.
Overall, Beyond Air Inc. aims to revolutionize the treatment of respiratory conditions by leveraging the therapeutic benefits of nitric oxide and delivering it directly to patients in a simple and efficient manner.
Company Address: 900 Stewart Avenue Garden City 11530 NY
Company Phone Number: 665-8200 Stock Exchange / Ticker: NASDAQ XAIR
|
11.54% 
-950 %